Medivir AB (publ) (LON:0GP7)
London
· Delayed Price · Currency is GBP · Price in SEK 1.760
-0.016 (-0.90%)
At close: Jun 4, 2025
Medivir AB Revenue
Medivir AB had revenue of 600.00K SEK in the quarter ending March 31, 2025, with 20.00% growth. This brings the company's revenue in the last twelve months to 3.58M, down -53.65% year-over-year. In the year 2024, Medivir AB had annual revenue of 3.48M, down -54.36%.
Revenue (ttm)
3.58M SEK
Revenue Growth
-53.65%
P/S Ratio
48.60
Revenue / Employee
358.40K SEK
Employees
10
Market Cap
13.43M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.48M | -4.15M | -54.36% |
| Dec 31, 2023 | 7.63M | 3.23M | 73.16% |
| Dec 31, 2022 | 4.41M | -27.99M | -86.39% |
| Dec 31, 2021 | 32.39M | 11.96M | 58.56% |
| Dec 31, 2020 | 20.43M | 11.71M | 134.18% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |